- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01824875
Temozolomide met of zonder capecitabine bij de behandeling van patiënten met gevorderde neuro-endocriene pancreastumoren
Een gerandomiseerde fase II-studie van temozolomide of temozolomide en capecitabine bij patiënten met gevorderde neuro-endocriene pancreastumoren
This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether temozolomide is more effective with or without capecitabine in treating patients with advanced pancreatic neuroendocrine tumors.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
PRIMARY OBJECTIVES:
I. To evaluate progression-free survival (PFS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
SECONDARY OBJECTIVES:
I. To evaluate response rates (RR) associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
II. To evaluate overall survival (OS) associated with temozolomide alone or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors.
III. To evaluate the toxicity associated with temozolomide alone or temozolomide and capecitabine treatment in patients with advanced pancreatic neuroendocrine tumors.
IV. To evaluate the usefulness of methyl guanine methyltransferase (MGMT) status (by immunohistochemistry [IHC] and promoter methylation) for predicting response in pancreatic neuroendocrine tumor patients treated with either temozolomide or temozolomide and capecitabine.
V. To bank radiology images for evaluation of quality, reproducibility, and compliance with computed tomography (CT) methodology.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM A: Patients receive temozolomide orally (PO) once daily (QD) on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
ARM B: Patients receive capecitabine PO twice daily (BID) on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years, and then every 6 months for 3 years.
Studietype
Inschrijving (Werkelijk)
Fase
- Fase 2
Contacten en locaties
Studie Locaties
-
-
California
-
Anaheim, California, Verenigde Staten, 92807
- Kaiser Anaheim Medical Center
-
Antioch, California, Verenigde Staten, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Baldwin Park, California, Verenigde Staten, 91706
- Kaiser Permanente Medical Group - Baldwin Park
-
Bellflower, California, Verenigde Staten, 90706
- Kaiser Foundation Hospital
-
Berkeley, California, Verenigde Staten, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Burlingame, California, Verenigde Staten, 94010
- Mills - Peninsula Hospitals
-
Fontana, California, Verenigde Staten, 92335
- Kaiser Permanente Hospital
-
Fremont, California, Verenigde Staten, 94538
- Kaiser Permanente, Fremont
-
Fresno, California, Verenigde Staten, 93720
- Kaiser Permanente
-
Harbor City, California, Verenigde Staten, 90710
- Kaiser Permanente - Harbor City
-
Hayward, California, Verenigde Staten, 94545
- Kaiser Permanente, Hayward
-
Irvine, California, Verenigde Staten, 92618
- Southern California Permanente Medical Group
-
Los Angeles, California, Verenigde Staten, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Verenigde Staten, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Verenigde Staten, 90033
- University of Southern California/Norris Cancer Center
-
Los Angeles, California, Verenigde Staten, 90034
- Kaiser Permanente-West Los Angeles
-
Modesto, California, Verenigde Staten, 95356
- Kaiser Permanente-Modesto
-
Novato, California, Verenigde Staten, 94945
- Sutter Cancer Research Consortium
-
Oakland, California, Verenigde Staten, 94611
- Kaiser Permanente-Oakland
-
Orange, California, Verenigde Staten, 92868
- University of California Medical Center At Irvine-Orange Campus
-
Panorama City, California, Verenigde Staten, 91402
- Kaiser Permanente - Panorama City
-
Redwood City, California, Verenigde Staten, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Verenigde Staten, 94801
- Kaiser Permanente-Richmond
-
Riverside, California, Verenigde Staten, 92505
- Kaiser Permanente Medical Center
-
Roseville, California, Verenigde Staten, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Verenigde Staten, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Verenigde Staten, 95825
- Kaiser Permanente - Sacramento
-
San Diego, California, Verenigde Staten, 92120
- Kaiser Permanente at San Diego
-
San Diego, California, Verenigde Staten, 92120
- Kaiser Permanente
-
San Francisco, California, Verenigde Staten, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Verenigde Staten, 94118
- California Pacific Medical Center
-
San Francisco, California, Verenigde Staten, 94115
- UCSF-Mount Zion
-
San Jose, California, Verenigde Staten, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Marcos, California, Verenigde Staten, 92069
- Kaiser Permanente Health Care
-
San Rafael, California, Verenigde Staten, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Verenigde Staten, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Verenigde Staten, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Verenigde Staten, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Verenigde Staten, 94080
- Kaiser Permanente-South San Francisco
-
Stanford, California, Verenigde Staten, 94305
- Stanford University Hospitals and Clinics
-
Stockton, California, Verenigde Staten, 95210
- Kaiser Permanente-Stockton
-
Vacaville, California, Verenigde Staten, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Verenigde Staten, 94589
- Kaiser Permanente-Vallejo
-
Vallejo, California, Verenigde Staten, 94589
- Sutter Solano Medical Center
-
Walnut Creek, California, Verenigde Staten, 94596
- Kaiser Permanente-Walnut Creek
-
Woodland Hills, California, Verenigde Staten, 91367
- Kaiser Permanente
-
-
Connecticut
-
Hartford, Connecticut, Verenigde Staten, 06105
- Saint Francis Hospital and Medical Center
-
Middletown, Connecticut, Verenigde Staten, 06457
- Middlesex Hospital
-
-
Delaware
-
Lewes, Delaware, Verenigde Staten, 19958
- Beebe Medical Center
-
Newark, Delaware, Verenigde Staten, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Verenigde Staten, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Verenigde Staten, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Verenigde Staten, 19718
- Christiana Care Health System-Christiana Hospital
-
Newark, Delaware, Verenigde Staten, 19713
- Christiana Gynecologic Oncology LLC
-
Newark, Delaware, Verenigde Staten, 19713
- Regional Hematology and Oncology PA
-
Rehoboth Beach, Delaware, Verenigde Staten, 19971
- Beebe Health Campus
-
Seaford, Delaware, Verenigde Staten, 19973
- Nanticoke Memorial Hospital
-
Wilmington, Delaware, Verenigde Staten, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
Florida
-
Jacksonville, Florida, Verenigde Staten, 32207
- Edna Williams Cancer Center at the Baptist Cancer Institute
-
Miami, Florida, Verenigde Staten, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Orlando, Florida, Verenigde Staten, 32803
- Florida Hospital
-
Tampa, Florida, Verenigde Staten, 33612
- H. Lee Moffitt Cancer Center and Research Institute
-
-
Hawaii
-
Honolulu, Hawaii, Verenigde Staten, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Verenigde Staten, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Verenigde Staten, 96819
- Kaiser Permanente Moanalua Medical Center
-
Honolulu, Hawaii, Verenigde Staten, 96813
- University of Hawaii
-
Honolulu, Hawaii, Verenigde Staten, 96813
- Oncare Hawaii Inc-POB II
-
Honolulu, Hawaii, Verenigde Staten, 96817-3169
- OnCare Hawaii-Liliha
-
Honolulu, Hawaii, Verenigde Staten, 96817
- Oncare Hawaii Inc-Kuakini
-
Kailua, Hawaii, Verenigde Staten, 96734
- Castle Medical Center
-
Lihue, Hawaii, Verenigde Staten, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Verenigde Staten, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Verenigde Staten, 96701
- Oncare Hawaii Inc-Pali Momi
-
-
Idaho
-
Boise, Idaho, Verenigde Staten, 83706
- Saint Alphonsus Regional Medical Center
-
-
Illinois
-
Bloomington, Illinois, Verenigde Staten, 61701
- Saint Joseph Medical Center
-
Bloomington, Illinois, Verenigde Staten, 61701
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Verenigde Staten, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Verenigde Staten, 62902
- Memorial Hospital of Carbondale
-
Carthage, Illinois, Verenigde Staten, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Verenigde Staten, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Verenigde Staten, 60611
- Northwestern University
-
Chicago, Illinois, Verenigde Staten, 60612
- University of Illinois
-
Decatur, Illinois, Verenigde Staten, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Verenigde Staten, 62526
- Cancer Care Center of Decatur
-
Effingham, Illinois, Verenigde Staten, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Verenigde Staten, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Verenigde Staten, 61401
- Illinois CancerCare Galesburg
-
Galesburg, Illinois, Verenigde Staten, 61401
- Illinois CancerCare-Galesburg Cottage Plaza Office
-
Highland Park, Illinois, Verenigde Staten, 60035
- Hematology Oncology Associates of Illinois-Highland Park
-
Hinsdale, Illinois, Verenigde Staten, 60521
- Hinsdale Hematology Oncology Associates Incorporated
-
Kankakee, Illinois, Verenigde Staten, 60901
- Presence Saint Mary's Hospital
-
Kewanee, Illinois, Verenigde Staten, 61443
- Illinois CancerCare-Kewanee Clinic
-
Libertyville, Illinois, Verenigde Staten, 60048
- North Shore Hematology Oncology
-
Macomb, Illinois, Verenigde Staten, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Verenigde Staten, 60153
- Loyola University Medical Center
-
Moline, Illinois, Verenigde Staten, 61265
- Garneau, Stewart C MD (UIA Investigator)
-
Moline, Illinois, Verenigde Staten, 61265
- Porubcin, Michael MD (UIA Investigator)
-
Moline, Illinois, Verenigde Staten, 61265
- Spector, David MD (UIA Investigator)
-
Moline, Illinois, Verenigde Staten, 61265
- Trinity Medical Center
-
Monmouth, Illinois, Verenigde Staten, 61462
- Illinois CancerCare-Monmouth
-
Mount Vernon, Illinois, Verenigde Staten, 62864
- Good Samaritan Regional Health Center
-
Niles, Illinois, Verenigde Staten, 60714
- Illinois Cancer Specialists-Niles
-
Normal, Illinois, Verenigde Staten, 61761
- Community Cancer Center Foundation
-
Ottawa, Illinois, Verenigde Staten, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Verenigde Staten, 61350
- Ottawa Regional Hospital and Healthcare Center
-
Pekin, Illinois, Verenigde Staten, 61554
- Pekin Cancer Treatment Center
-
Pekin, Illinois, Verenigde Staten, 61603
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Verenigde Staten, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Verenigde Staten, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Verenigde Staten, 61614
- Proctor Hospital
-
Peoria, Illinois, Verenigde Staten, 61603
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Verenigde Staten, 61615
- Illinois Oncology Research Association CCOP
-
Peru, Illinois, Verenigde Staten, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Verenigde Staten, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Verenigde Staten, 61107
- SwedishAmerican Regional Cancer Center/ACT
-
Skokie, Illinois, Verenigde Staten, 60076
- Hematology Oncology Associates of Illinois - Skokie
-
Springfield, Illinois, Verenigde Staten, 62781-0001
- Memorial Medical Center
-
-
Indiana
-
Indianapolis, Indiana, Verenigde Staten, 46237
- Franciscan Saint Francis Health-Indianapolis
-
Richmond, Indiana, Verenigde Staten, 47374
- Reid Hospital and Health Care Services
-
-
Iowa
-
Ames, Iowa, Verenigde Staten, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Verenigde Staten, 50010
- McFarland Clinic PC-William R Bliss Cancer Center
-
Bettendorf, Iowa, Verenigde Staten, 52722
- Constantinou, Costas L MD (UIA Investigator)
-
Boone, Iowa, Verenigde Staten, 50036
- McFarland Clinic PC-Boone
-
Clive, Iowa, Verenigde Staten, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Verenigde Staten, 50325
- Medical Oncology and Hematology Associates-West Des Moines
-
Des Moines, Iowa, Verenigde Staten, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Verenigde Staten, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Verenigde Staten, 50309
- Medical Oncology and Hematology Associates-Des Moines
-
Des Moines, Iowa, Verenigde Staten, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Verenigde Staten, 50314
- Medical Oncology and Hematology Associates-Laurel
-
Des Moines, Iowa, Verenigde Staten, 50309
- Iowa Oncology Research Association CCOP
-
Jefferson, Iowa, Verenigde Staten, 50129
- McFarland Clinic PC-Jefferson
-
Marshalltown, Iowa, Verenigde Staten, 50158
- McFarland Clinic PC-Marshalltown
-
Sioux City, Iowa, Verenigde Staten, 51104
- Saint Luke's Regional Medical Center
-
Sioux City, Iowa, Verenigde Staten, 51101
- Siouxland Hematology Oncology Associates
-
Sioux City, Iowa, Verenigde Staten, 51104
- Mercy Medical Center-Sioux City
-
West Des Moines, Iowa, Verenigde Staten, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Verenigde Staten, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Chanute, Kansas, Verenigde Staten, 66720
- Cancer Center of Kansas - Chanute
-
Dodge City, Kansas, Verenigde Staten, 67801
- Cancer Center of Kansas - Dodge City
-
El Dorado, Kansas, Verenigde Staten, 67042
- Cancer Center of Kansas - El Dorado
-
Fort Scott, Kansas, Verenigde Staten, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, Verenigde Staten, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, Verenigde Staten, 67068
- Cancer Center of Kansas-Kingman
-
Lawrence, Kansas, Verenigde Staten, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, Verenigde Staten, 67901
- Cancer Center of Kansas-Liberal
-
Manhattan, Kansas, Verenigde Staten, 66502
- Cancer Center of Kansas-Manhattan
-
McPherson, Kansas, Verenigde Staten, 67460
- Cancer Center of Kansas - McPherson
-
Newton, Kansas, Verenigde Staten, 67114
- Cancer Center of Kansas - Newton
-
Parsons, Kansas, Verenigde Staten, 67357
- Cancer Center of Kansas - Parsons
-
Pratt, Kansas, Verenigde Staten, 67124
- Cancer Center of Kansas - Pratt
-
Salina, Kansas, Verenigde Staten, 67401
- Cancer Center of Kansas - Salina
-
Wellington, Kansas, Verenigde Staten, 67152
- Cancer Center of Kansas - Wellington
-
Wichita, Kansas, Verenigde Staten, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Verenigde Staten, 67208
- Associates In Womens Health
-
Wichita, Kansas, Verenigde Staten, 67214
- Cancer Center of Kansas - Main Office
-
Wichita, Kansas, Verenigde Staten, 67214
- Via Christi Regional Medical Center
-
Wichita, Kansas, Verenigde Staten, 67214
- Wichita CCOP
-
Winfield, Kansas, Verenigde Staten, 67156
- Cancer Center of Kansas - Winfield
-
-
Kentucky
-
Crestview Hills, Kentucky, Verenigde Staten, 41017
- Oncology Hematology Care Incorporated
-
-
Louisiana
-
Baton Rouge, Louisiana, Verenigde Staten, 70809
- Ochsner Health Center-Summa
-
New Orleans, Louisiana, Verenigde Staten, 70121
- Ochsner Medical Center Jefferson
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02118
- Boston Medical Center
-
Burlington, Massachusetts, Verenigde Staten, 01805
- Lahey Hospital and Medical Center
-
-
Michigan
-
Adrian, Michigan, Verenigde Staten, 49221
- Bixby Medical Center
-
Adrian, Michigan, Verenigde Staten, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Verenigde Staten, 48106-0995
- Saint Joseph Mercy Hospital
-
Ann Arbor, Michigan, Verenigde Staten, 48106
- Michigan Cancer Research Consortium Community Clinical Oncology Program
-
Ann Arbor, Michigan, Verenigde Staten, 48109
- University of Michigan University Hospital
-
Dearborn, Michigan, Verenigde Staten, 48124
- Oakwood Hospital
-
Detroit, Michigan, Verenigde Staten, 48236
- Saint John Hospital and Medical Center
-
Flint, Michigan, Verenigde Staten, 48502
- Hurley Medical Center
-
Flint, Michigan, Verenigde Staten, 48503
- Genesys Hurley Cancer Institute
-
Jackson, Michigan, Verenigde Staten, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Verenigde Staten, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Verenigde Staten, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Verenigde Staten, 49001
- Borgess Medical Center
-
Lansing, Michigan, Verenigde Staten, 48912
- Sparrow Hospital
-
Livonia, Michigan, Verenigde Staten, 48154
- Saint Mary Mercy Hospital
-
Monroe, Michigan, Verenigde Staten, 48162
- Mercy Memorial Hospital
-
Monroe, Michigan, Verenigde Staten, 48162
- Community Cancer Center of Monroe
-
Pontiac, Michigan, Verenigde Staten, 48341-2985
- Saint Joseph Mercy Oakland
-
Port Huron, Michigan, Verenigde Staten, 48060
- Saint Joseph Mercy Port Huron
-
Saginaw, Michigan, Verenigde Staten, 48601
- Saint Mary's of Michigan
-
Warren, Michigan, Verenigde Staten, 48093
- Saint John Macomb-Oakland Hospital
-
-
Minnesota
-
Burnsville, Minnesota, Verenigde Staten, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Verenigde Staten, 55433
- Mercy Hospital
-
Edina, Minnesota, Verenigde Staten, 55435
- Fairview-Southdale Hospital
-
Fridley, Minnesota, Verenigde Staten, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Verenigde Staten, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Verenigde Staten, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Verenigde Staten, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Verenigde Staten, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Verenigde Staten, 55407
- Abbott-Northwestern Hospital
-
New Ulm, Minnesota, Verenigde Staten, 56073
- New Ulm Medical Center
-
Robbinsdale, Minnesota, Verenigde Staten, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Verenigde Staten, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Verenigde Staten, 55416
- Metro-Minnesota CCOP
-
Saint Paul, Minnesota, Verenigde Staten, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Verenigde Staten, 55102
- United Hospital
-
Shakopee, Minnesota, Verenigde Staten, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Verenigde Staten, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Verenigde Staten, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Verenigde Staten, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Verenigde Staten, 55125
- Minnesota Oncology and Hematology PA-Woodbury
-
-
Missouri
-
Bolivar, Missouri, Verenigde Staten, 65613
- Central Care Cancer Center-Carrie J Babb Cancer Center
-
Branson, Missouri, Verenigde Staten, 65616
- CoxHealth Cancer Center
-
Cape Girardeau, Missouri, Verenigde Staten, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Verenigde Staten, 63703
- Southeast Cancer Center
-
Jefferson City, Missouri, Verenigde Staten, 65109
- Capital Region Medical Center-Goldschmidt Cancer Center
-
Rolla, Missouri, Verenigde Staten, 65401
- Phelps County Regional Medical Center
-
Rolla, Missouri, Verenigde Staten, 65401
- Saint John's Clinic-Rolla-Cancer and Hematology
-
Springfield, Missouri, Verenigde Staten, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Verenigde Staten, 65804
- Mercy Hospital Springfield
-
Springfield, Missouri, Verenigde Staten, 65802
- Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
-
St Louis, Missouri, Verenigde Staten, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Verenigde Staten, 63109
- Saint Louis Cancer and Breast Institute-South City
-
St Louis, Missouri, Verenigde Staten, 63141
- Saint John's Mercy Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Verenigde Staten, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89106
- Nevada Cancer Research Foundation CCOP
-
-
New Jersey
-
Camden, New Jersey, Verenigde Staten, 08103
- Cooper Hospital University Medical Center
-
Mount Holly, New Jersey, Verenigde Staten, 08060
- Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
-
Voorhees Township, New Jersey, Verenigde Staten, 08043
- Virtua West Jersey Hospital Voorhees
-
-
New York
-
Albany, New York, Verenigde Staten, 12208
- New York Oncology Hematology PC -Albany Medical Center
-
Albany, New York, Verenigde Staten, 12206
- New York Oncology Hematology PC - Albany
-
Amsterdam, New York, Verenigde Staten, 12010
- New York Oncology Hematology PC - Amsterdam
-
Hudson, New York, Verenigde Staten, 12534
- New York Oncology Hematology PC-Hudson
-
Latham, New York, Verenigde Staten, 12110
- New York Oncology Hematology PC - Latham
-
Rexford, New York, Verenigde Staten, 12148
- New York Oncology Hematology PC - Rexford
-
Rochester, New York, Verenigde Staten, 14642
- University of Rochester
-
The Bronx, New York, Verenigde Staten, 10467-2490
- Montefiore Medical Center
-
The Bronx, New York, Verenigde Staten, 10461
- Montefiore Medical Center-Weiler Division
-
Troy, New York, Verenigde Staten, 12180
- New York Oncology Hematology PC - Troy
-
-
North Carolina
-
Kinston, North Carolina, Verenigde Staten, 28501
- Kinston Medical Specialists PA
-
Statesville, North Carolina, Verenigde Staten, 28677
- Iredell Memorial Hospital
-
-
Ohio
-
Akron, Ohio, Verenigde Staten, 44307
- Akron General Medical Center
-
Beachwood, Ohio, Verenigde Staten, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Belpre, Ohio, Verenigde Staten, 45714
- Strecker Cancer Center-Belpre
-
Bowling Green, Ohio, Verenigde Staten, 43402
- Toledo Clinic Cancer Centers-Bowling Green
-
Chillicothe, Ohio, Verenigde Staten, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Verenigde Staten, 45267
- University of Cincinnati
-
Cincinnati, Ohio, Verenigde Staten, 45230
- Oncology Hematology Care Inc - Anderson
-
Cincinnati, Ohio, Verenigde Staten, 45236
- Oncology Hematology Care Inc - Kenwood
-
Cincinnati, Ohio, Verenigde Staten, 45219
- Oncology and Hematology Care Incorporated
-
Cincinnati, Ohio, Verenigde Staten, 45242
- Oncology and Hematology Care Inc - Blue Ash
-
Cincinnati, Ohio, Verenigde Staten, 45248
- Oncology Hematology Care Inc - Western Hills
-
Cleveland, Ohio, Verenigde Staten, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Verenigde Staten, 44195
- Cleveland Clinic Foundation
-
Columbus, Ohio, Verenigde Staten, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Verenigde Staten, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Verenigde Staten, 43210
- Ohio State University Medical Center
-
Columbus, Ohio, Verenigde Staten, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Verenigde Staten, 43228
- Doctors Hospital
-
Columbus, Ohio, Verenigde Staten, 43215
- Grant Medical Center
-
Columbus, Ohio, Verenigde Staten, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, Verenigde Staten, 43215
- Columbus CCOP
-
Dayton, Ohio, Verenigde Staten, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Verenigde Staten, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Verenigde Staten, 45415
- Samaritan North Health Center
-
Dayton, Ohio, Verenigde Staten, 45405
- Grandview Hospital
-
Dayton, Ohio, Verenigde Staten, 45420
- Dayton CCOP
-
Delaware, Ohio, Verenigde Staten, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Verenigde Staten, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Verenigde Staten, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, Verenigde Staten, 44035
- Mercy Cancer Center-Elyria
-
Elyria, Ohio, Verenigde Staten, 44035
- Hematology Oncology Center Incorporated
-
Fairfield, Ohio, Verenigde Staten, 45014
- Oncology Hematology Care Inc
-
Findlay, Ohio, Verenigde Staten, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Verenigde Staten, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Verenigde Staten, 45331
- Wayne Hospital
-
Independence, Ohio, Verenigde Staten, 44131
- Cleveland Clinic Cancer Center Independence
-
Kettering, Ohio, Verenigde Staten, 45429
- Kettering Medical Center
-
Lancaster, Ohio, Verenigde Staten, 43130
- Fairfield Medical Center
-
Lancaster, Ohio, Verenigde Staten, 43130
- Lancaster Radiation Oncology
-
Lima, Ohio, Verenigde Staten, 45801
- Saint Rita's Medical Center
-
Lima, Ohio, Verenigde Staten, 45804
- Lima Memorial Hospital
-
Marietta, Ohio, Verenigde Staten, 45750
- Marietta Memorial Hospital
-
Maumee, Ohio, Verenigde Staten, 43537
- Toledo Clinic Cancer Centers-Maumee
-
Maumee, Ohio, Verenigde Staten, 43537
- Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
-
Mayfield Heights, Ohio, Verenigde Staten, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Verenigde Staten, 43050
- Knox Community Hospital
-
Newark, Ohio, Verenigde Staten, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Verenigde Staten, 43055
- Newark Radiation Oncology
-
Oregon, Ohio, Verenigde Staten, 43616
- Saint Charles Hospital
-
Oregon, Ohio, Verenigde Staten, 43616
- Toledo Clinic Cancer Centers-Oregon
-
Portsmouth, Ohio, Verenigde Staten, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Verenigde Staten, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Verenigde Staten, 45505
- Springfield Regional Medical Center
-
Strongsville, Ohio, Verenigde Staten, 44136
- Cleveland Clinic Cancer Center-Strongsville
-
Sylvania, Ohio, Verenigde Staten, 43560
- Flower Hospital
-
Tiffin, Ohio, Verenigde Staten, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Verenigde Staten, 43608
- Saint Vincent Mercy Medical Center
-
Toledo, Ohio, Verenigde Staten, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Toledo, Ohio, Verenigde Staten, 43614
- University of Toledo
-
Toledo, Ohio, Verenigde Staten, 43617
- Toledo Community Hospital Oncology Program CCOP
-
Toledo, Ohio, Verenigde Staten, 43606
- The Toledo Hospital/Toledo Children's Hospital
-
Toledo, Ohio, Verenigde Staten, 43623
- Mercy Saint Anne Hospital
-
Troy, Ohio, Verenigde Staten, 45373
- Upper Valley Medical Center
-
Wauseon, Ohio, Verenigde Staten, 43567
- Fulton County Health Center
-
Westerville, Ohio, Verenigde Staten, 43081
- Saint Ann's Hospital
-
Xenia, Ohio, Verenigde Staten, 45385
- Greene Memorial Hospital
-
Zanesville, Ohio, Verenigde Staten, 43701
- Genesis HealthCare System
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Verenigde Staten, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Verenigde Staten, 74146
- Tulsa Cancer Institute
-
-
Pennsylvania
-
Danville, Pennsylvania, Verenigde Staten, 17822-2001
- Geisinger Medical Center
-
Hazleton, Pennsylvania, Verenigde Staten, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey, Pennsylvania, Verenigde Staten, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Lewisburg, Pennsylvania, Verenigde Staten, 17837
- Geisinger Medical Oncology at Evangelical Community Hospital
-
Philadelphia, Pennsylvania, Verenigde Staten, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Verenigde Staten, 19107
- Thomas Jefferson University Hospital
-
Pottsville, Pennsylvania, Verenigde Staten, 17901
- Geisinger Medical Oncology-Pottsville
-
State College, Pennsylvania, Verenigde Staten, 16801
- Geisinger Medical Group
-
West Reading, Pennsylvania, Verenigde Staten, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Verenigde Staten, 18711
- Geisinger Wyoming Valley
-
-
South Carolina
-
Greenville, South Carolina, Verenigde Staten, 29605
- Greenville Health System Cancer Institute-Butternut
-
Greenville, South Carolina, Verenigde Staten, 29615
- Greenville Health System Cancer Institute/Greenville CCOP
-
Greer, South Carolina, Verenigde Staten, 29650
- Greenville Health System Cancer Institute-Greer
-
-
Tennessee
-
Nashville, Tennessee, Verenigde Staten, 37232-6838
- Vanderbilt Cancer Center
-
-
Virginia
-
Fredericksburg, Virginia, Verenigde Staten, 22401
- Fredericksburg Oncology Inc
-
-
Wisconsin
-
La Crosse, Wisconsin, Verenigde Staten, 54601
- Gundersen Lutheran
-
Madison, Wisconsin, Verenigde Staten, 53792
- University of Wisconsin Hospital and Clinics
-
Milwaukee, Wisconsin, Verenigde Staten, 53226
- Froedtert and the Medical College of Wisconsin
-
New Richmond, Wisconsin, Verenigde Staten, 54017
- Cancer Center of Western Wisconsin
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
Patient must have histologically or pathologically confirmed locally unresectable or metastatic low or intermediate grade pancreatic neuroendocrine tumor
-
Patient must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria; baseline measurements and evaluations of all sites of disease must be obtained <= 4 weeks prior to randomization and must be acquired by multiphasic CT or contrast magnetic resonance imaging (MRI)
-
Date of last documented disease progression must be within 12 months from date of randomization
-
Prior everolimus and/or sunitinib therapy is allowed, so long as it was discontinued >= 4 weeks prior to randomization
-
Concurrent somatostatin analogues are allowed provided that patients
- Have been on a stable dose for 8 weeks and
- Have documented disease progression on that dose
-
Chemoembolization is allowed if ≥ 4 weeks from study entry. There are 2 possible scenarios:
- If patient has hepatic disease only: they need to have progressed in the liver since chemoembolization and have measurable disease by RECIST 1.1 in order to be eligible.
- If patient has hepatic and extrahepatic disease: they will need to have progressed inside OR outside the liver and have measureable disease by RECIST 1.1 in order to be eligible.
-
Leukocytes >= 3,000/mm^3
-
Absolute neutrophil count >= 1,500/mm^3
-
Hemoglobin >= 9 g/dL
-
Platelets >= 100,000/mm^3
-
Total bilirubin <= institutional upper limit of normal (ULN) or <= 1.5 X institutional ULN (if the patient has liver metastases)
-
Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) <= 3 X institutional ULN or (<= 5 X institutional ULN if the patient has liver metastases)
-
Serum creatinine <= 1.5 X institutional ULN
-
Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1
-
Patient must have life expectancy >= 12 weeks all females of childbearing potential must have a blood test or urine study within =< 2 weeks prior to randomization to rule out pregnancy; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Women of childbearing potential and sexually active males must be strongly advised to use an accepted and effective method of contraception or to abstain from sexual intercourse for the duration of their participation in the study; should a woman become pregnant while participating in this study, she should inform her treating physician immediately; if a man impregnates a woman while participating in this study, he should inform his treating physician immediately
-
Patient must be able to swallow pills
-
Patient must be able to tolerate CT or magnetic resonance (MR) imaging including contrast agents as required for their treatment and the protocol
Exclusion Criteria:
-
Small cell carcinoma
-
Prior temozolomide, dacarbazine (DTIC), or capecitabine, or 5-FU (fluorouracil) therapy
-
Receiving any other investigational agents while on study treatment
-
Receiving Coumadin while on treatment; other anticoagulants are allowed
-
Patients with either clinically apparent central nervous system metastases or carcinomatous meningitis are ineligible
-
Active or uncontrolled infection or serious medical or psychiatric illness
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to temozolomide or capecitabine
-
Absorption issues that would limit the ability to absorb study agents
-
Patients with a history of the following within 12 months of study entry:
- Arterial thromboembolic events
- Unstable angina
- Myocardial Infarction
-
Symptomatic peripheral vascular disease
-
Patients with previous or concurrent malignancy; exceptions are made for patients who meet any of the following conditions:
- Non-melanoma skin cancer, in situ cervical cancer, or breast cancer in situ OR
- Prior malignancy completely excised or removed and patient has been continuously disease free for > 5 years OR
- Prior malignancy cured by non-surgical modalities and patient has been continuously disease free for > 5 years
-
Pregnant or breast-feeding
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Arm A (temozolomide)
Patients receive temozolomide PO QD on days 1-5. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Andere namen:
|
|
Experimenteel: Arm B (temozolomide and capecitabine)
Patients receive capecitabine PO BID on days 1-14 and temozolomide PO QD on days 10-14. Treatment repeats every 28 days for up to 13 courses in the absence of disease progression or unacceptable toxicity. |
Given PO
Andere namen:
Given PO
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Progression-free Survival
Tijdsspanne: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Progression-free survival (PFS) is defined as the time from randomization to progression or death without evidence of progression. Progression was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. Kaplan-Meier method was used to estimate PFS. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Proportion of Patients With Response
Tijdsspanne: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Overall Survival
Tijdsspanne: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Overall survival is defined as time from randomization to death or date last known alive. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Immunohistochemistry (IHC) and Response
Tijdsspanne: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status was determined by IHC using paraffin-embedded sections of 4µm. A score (H-score) was generated based on the findings and scoring was performed by two pathologists. This H-score ranges from 0 (no staining in the tumor) to 300 (diffuse intense staining of the tumor). The highest score was used if there was disagreement. H-scores were grouped into 3 standard categories for MGMT status: Category 1 - <=50 Category 2 - 51-100 Category 3 - >100 |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
|
Association Between Methyl Guanine Methyltransferase (MGMT) Status by Promoter Methylation and Response
Tijdsspanne: Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Response was evaluated using the revised Response Evaluation Criteria in Solid Tumors (RECIST) guideline (version 1.1) and defined as either complete response (CR) or partial response (PR). CR is defined as disappearance of all target lesions. Any pathological lymph nodes (whether target or non-target) must have reduction in short axis to < 10 mm. PR is defined as at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. MGMT status is determined by promoter methylation, a clinically validated methylation-specific polymerase chain reaction (PCR) analysis. A tumor sample is considered positive for MGMT promoter methylation if an 80bp band is detected in the methylated PCR reaction. It would be considered MGMT negative if an 80bp band is not detected in the methylated PCR reaction. |
Assessed every 3 months for 3 years and then every 6 months for years 3-5
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Pamela Kunz, ECOG-ACRIN Cancer Research Group
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Geschat)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Endocriene systeemziekten
- Neoplasmata per site
- Neoplasmata
- Neoplasmata per histologisch type
- Neoplasmata van het spijsverteringsstelsel
- Ziekten van het spijsverteringsstelsel
- Endocriene klierneoplasmata
- Alvleesklier Ziekten
- Neoplasmata, glandulair en epitheel
- Adenocarcinoom
- Adenoom
- Carcinoom
- Neuro-ectodermale tumoren
- Neoplasmata, kiemcellen en embryonaal
- Neuro-endocriene tumoren
- Carcinoom, neuro-endocrien
- Pancreasneoplasmata
- Adenoom, eilandcel
- Carcinoom, eilandcel
- Gastrinoom
- Insulinoom
- Glucagonoom
- Somatostatinoom
- Organische chemicaliën
- Heterocyclische verbindingen, 1-ring
- Heterocyclische verbindingen
- Azoles
- Nucleïnezuren, nucleotiden en nucleosiden
- Dacarbazine
- Triazenen
- Imidazolen
- Deoxycytidine
- Cytidine
- Pyrimidine -nucleosiden
- Pyrimidines
- Nucleosiden
- Uracil
- Pyrimidinonen
- Deoxyribonucleosides
- Fluorouracil
- Temozolomide
- Capecitabine
Andere studie-ID-nummers
- E2211
- U10CA180820 (Subsidie/contract van de Amerikaanse NIH)
- U10CA021115 (Subsidie/contract van de Amerikaanse NIH)
- E2211 (Andere identificatie: ECOG-ACRIN Cancer Research Group)
- NCI-2012-02007 (Register-ID: CTRP (Clinical Trial Reporting Program))
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .